Yingran Xu

Glucose-Targeted Hydroxyapatite/Indocyanine Green Hybrid Nanoparticles for Collaborative Tumor Therapy.

Xu Cheng, Rupei Tang, Conghu Li, 2021, ACS applied materials & interfaces.

Dual-pH responsive chitosan nanoparticles for improving in vivo drugs delivery and chemoresistance in breast cancer.

Xu Cheng, Conghu Li, Yingran Xu, 2022, Carbohydrate polymers.

A sequentially responsive cascade nanoplatform for increasing chemo-chemodynamic therapy.

Conghu Li, B. Wei, Lu Wang, 2022, Colloids and surfaces. B, Biointerfaces.

Acid-sensitive and L61-crosslinked hyaluronic acid nanogels for overcoming tumor drug-resistance.

Xu Cheng, Rupei Tang, Conghu Li, 2021, International journal of biological macromolecules.

Development of antioxidant and smart NH3 -sensing packaging film by incorporating bilirubin into κ-carrageenan matrix.

Yingnan Liu, Yaqing Xiao, G. Xiong, 2023, The Journal of the Science of Food and Agriculture.